Author Profile

Mary Powers

Mary Powers

Mary Powers is a former member of the Strategic Communications, Education and Outreach Department at St. Jude Children’s Research Hospital.

Stories by Mary Powers

Lando: Star Wars smuggler or possible ally against Alzheimer’s disease?
Lando: Star Wars smuggler or possible ally against Alzheimer’s disease?
Research

Lando: Star Wars smuggler or possible ally against Alzheimer’s disease?

Mary Powers

High science calls on Star Wars character as a potential ally against Alzheimer’s disease.

Life after cancer: Researchers work to understand and ease the cognitive challenges that childhood cancer survivors face
Life after cancer: Researchers work to understand and ease the cognitive challenges that childhood cancer survivors face
Clinical

Life after cancer: Researchers work to understand and ease the cognitive challenges that childhood cancer survivors face

Mary Powers

Childhood cancer treatment is one of the great medical successes of recent decades. But that success comes with a price.

CAR T cells: Are they the horizon for treatment of solid tumors?
CAR T cells: Are they the horizon for treatment of solid tumors?
Research

CAR T cells: Are they on the horizon for treatment of solid tumors?

Mary Powers

Ongoing research on CAR T-cell therapy, heralded as a miracle cure, shows promise for treating solid tumors. How close are we?

The St. Jude equation: A better method of calculating kidney function
The St. Jude equation: A better method of calculating kidney function
Clinical

The St. Jude Equations: A better method of calculating kidney function

Mary Powers

Learn about new equations to estimate kidney function in young cancer patients more quickly and accurately.

Why does the risk of pediatric leukemia relapse vary by race? - St. Jude Progress Blog
Why does the risk of pediatric leukemia relapse vary by race? - St. Jude Progress Blog
Research

Why does the risk of pediatric acute lymphoblastic leukemia relapse vary by race?

Mary Powers

These inherited gene variations may help explain why the risk of relapse for children with acute lymphoblastic leukemia varies by race.